Results 281 to 290 of about 25,082 (343)

A Dose‐Tailored Anti‐Plasma Cell Regimen Lowers the Mortality of Late‐Stage Cardiac Amyloidosis

open access: yesMedComm, Volume 6, Issue 7, July 2025.
The present study was designed to assess the efficacy and safety of a dose‐tailored BD regimen and a dose‐tailored DBD regimen in patients with LCCA at Mayo Stage III. Both the two regimens markedly increased survival rate and time in those patients and the dose‐tailored DBD regimen was superior to the dose‐tailored BD regimen in both efficacy and ...
Yun Ti   +8 more
wiley   +1 more source

The interplay between heart failure and chronic kidney disease

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 7, Page 3568-3582, July 2025.
Abstract Chronic kidney disease (CKD) and heart failure (HF) are two globally prevalent, independent, long‐term conditions, which often coexist in an individual and display a bidirectional yet interconnected relationship. The presence of CKD often leads to the development of HF and vice versa, which propagates the worsening of each disease, reflecting ...
Anuradha Lala   +2 more
wiley   +1 more source

Berg Balance Scale score is a valuable predictor of all-cause mortality among acute decompensated heart failure patients. [PDF]

open access: yesJ Geriatr Cardiol
Fan YX   +9 more
europepmc   +1 more source

Transitional changes in medication‐initiator cohort profiles in persons with chronic kidney disease and type 2 diabetes—A hospital‐based cohort study in Japan

open access: yesDiabetes, Obesity and Metabolism, Volume 27, Issue 7, Page 3714-3724, July 2025.
Abstract Aims To describe temporal changes in the characteristics of medication‐initiator cohorts in persons with chronic kidney disease (CKD) and type 2 diabetes (T2D). Materials and Methods Adults with CKD and T2D initiating sodium‐glucose cotransporter‐2 inhibitors (SGLT‐2i) or glucagon‐like peptide‐1 receptor agonists (GLP‐1RA) were identified in ...
Yuichiro Yano   +9 more
wiley   +1 more source

Long‐Term Outcomes of Mitral Valve Repair With Artificial Chordae and Annuloplasty for Myxomatous Mitral Valve Disease in Dogs

open access: yesJournal of Veterinary Internal Medicine, Volume 39, Issue 4, July/August 2025.
ABSTRACT Background Myxomatous mitral valve disease (MMVD) in dogs commonly progresses to congestive heart failure, which carries a poor prognosis. Mitral valve repair (MVR) is a recognized treatment for advanced‐stage MMVD. Hypothesis/Objectives Identify the risk factors and prognosis in dogs undergoing MVR.
Kentaro Kurogochi   +6 more
wiley   +1 more source

Exploratory Study of CD10low Polymorphonuclear Leukocytes Preceding and Correlating With Postsurgical Inflammation

open access: yesScandinavian Journal of Immunology, Volume 102, Issue 1, July 2025.
The present exploratory study aimed to assess whether cellular immune monitoring could be an option to detect the postsurgical inflammatory response in patients undergoing cardiac surgery of aortic valve replacement accompanied with extracorporeal circulation.
Timo Michael Westermann   +11 more
wiley   +1 more source

Association Between <i>Porphyromonas gingivalis</i> and Alzheimer's Disease: A Comprehensive Review. [PDF]

open access: yesInfect Drug Resist
Sarmiento-Ordóñez JM   +3 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy